Theratechnologies Sets $118k Yearly Price For HIV Biologic Trogarzo

 
• By Emily Hayes

The company's monoclonal antibody for multidrug resistant HIV-1 patients licensed from TaiMed will launch soon.

Digital illustration of HIV Virus in Blood Stream in color background

More from New Products

More from Scrip